Reeves R A, Smith D L, Leenen F H
Clin Pharmacol Ther. 1987 Mar;41(3):326-35. doi: 10.1038/clpt.1987.35.
To assess the effects of nonselective vs. beta 1-selective beta-blockade on the hyperdynamic circulation induced by hydralazine, eight healthy volunteers received placebo, propranolol, 20 and 40 mg, and atenolol, 25 and 50 mg, on 5 separate days, followed by hydralazine (range 75 to 150 mg). Hydralazine decreased afterload (end-systolic wall stress) and increased venous return and left ventricular performance (by M-mode echocardiography). Both beta-blockers blunted the increases in heart rate, cardiac output, and venous return similarly, although heart rate and cardiac output were not completely normalized. Atenolol did not affect the hydralazine-induced decrease in afterload, whereas propranolol significantly opposed this change (P less than 0.03). The hyperdynamic circulation seen with hydralazine is mostly beta mediated, primarily beta 1. When given with hydralazine the two beta-blocker types differ primarily in their effects on afterload.
为评估非选择性β受体阻滞剂与β1选择性β受体阻滞剂对肼屈嗪所致高动力循环的影响,8名健康志愿者在5个不同日期分别接受安慰剂、20毫克和40毫克普萘洛尔以及25毫克和50毫克阿替洛尔,随后给予肼屈嗪(剂量范围为75至150毫克)。肼屈嗪降低后负荷(收缩末期壁应力),并增加静脉回流和左心室功能(通过M型超声心动图测量)。两种β受体阻滞剂对心率、心输出量和静脉回流增加的抑制作用相似,尽管心率和心输出量未完全恢复正常。阿替洛尔不影响肼屈嗪所致的后负荷降低,而普萘洛尔则显著对抗这一变化(P<0.03)。肼屈嗪引起的高动力循环主要由β介导,主要是β1。与肼屈嗪合用时,两种类型的β受体阻滞剂主要在对后负荷的影响方面存在差异。